Evaluation of  clinical efficacy of dydrogesterone in hormonal replacement therapy

Grzegorz Stachowiak; Tomasz Pertyński

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2004
vol. 3

Send email

Copy url:

abstract:

Evaluation of clinical efficacy of dydrogesterone in hormonal replacement therapy

Grzegorz Stachowiak

,

Tomasz Pertyński

Prze Menopauz 2004; 2: 13–21

Online publish date: 2004/04/02

View full text Get citation

Dydrogesterone is a highly selective progestin freed from many side-effects characteristic for this type of drugs. The authors presented clinical and metabolic effects of its application in menopausal women in view of the risk of breast cancer, vaginal bleeding control, impact on endometrium, lipid profile, cardiovascular risk, and mineral bone density. The positive influence on the above parameters makes dydrogesterone a good alternative to other progestins administered as part of the hormone replacement therapy.

keywords:

Evaluation of clinical efficacy of dydrogesterone in hormonal replacement therapy

Grzegorz Stachowiak , Tomasz Pertyński

dydrogesterone, HRT, menopause, breast cancer

Grzegorz Stachowiak

,

Tomasz Pertyński